02 NCAC 09H .0109
Notwithstanding the limits set forth in FDA Compliance Policy Guide incorporated by reference in 02 NCAC 09B .0116(f), reaching or exceeding the following limits shall constitute product adulteration pursuant to G.S. 106‑129(1)c. requiring embargo and voluntary recall by manufacturer:
History Note: Authority G.S. 106‑139; 106‑267; 106‑267.2;
Eff. February 1, 1976;
Amended Eff. January 1, 1985;
Readopted Eff. March 1, 2017.